To allow the importation by individuals of safe and affordable drugs from Canada.
Legislative Activity
Stay on top of the latest movement without scrolling through every action
Senate amendment proposed (on the floor): Amendment SA 2107 proposed by Senator McCain.(consideration: CR S3536-3540, 23540, S3541-3542, S3543-3545, S3559-3561, S3562; text: CR S3536-3537)
May 24, 2012
View full timeline
Senate amendment proposed (on the floor): Amendment SA 2107 proposed by Senator McCain.(consideration: CR S3536-3540, 23540, S3541-3542, S3543-3545, S3559-3561, S3562; text: CR S3536-3537)
May 24, 2012
Roll call votes on amendments in Senate: Amendment SA 2107, under the order of 5/23/12, not having achieved 60 votes in the affirmative, was not agreed to in Senate by Yea-Nay Vote. 43 - 54. Record Vote Number: 108.
May 24, 2012
Senate amendment not agreed to: Amendment SA 2107, under the order of 5/23/12, not having achieved 60 votes in the affirmative, was not agreed to in Senate by Yea-Nay Vote. 43 - 54. Record Vote Number: 108.
May 24, 2012
Amendment SA 2107 proposed by Senator McCain. (consideration: CR S3536-3540, 23540, S3541-3542, S3543-3545, S3559-3561, S3562; text: CR S3536-3537) To allow the importation by individuals of safe and affordable drugs from Canada.
May 24, 2012
Amendment SA 2107, under the order of 5/23/12, not having achieved 60 votes in the affirmative, was not agreed to in Senate by Yea-Nay Vote. 43 - 54. Record Vote Number: 108.
May 24, 2012
Senate amendment submitted
May 17, 2012
Votes
1 roll call on this amendment
Text
Submitted
SA 2107. Mr. McCAIN submitted an amendment intended to be proposed by him to the bill S. 3187, to amend the Federal Food, Drug, and Cosmetic Act to revise and extend the user-fee programs for prescription drugs and medical devices, to establish user-fee programs for generic drugs and biosimilars, and for other purposes; which was ordered to lie on the table; as follows: At the end of title XI, add the following: SEC. 11__. SAFE AND AFFORDABLE DRUGS FROM CANADA. Chapter VIII of the Federal Food, Drug, and Cosmetic Act (21 U.S.C. 381 et seq.), as amended by this Act, is further amended by adding at the end the following: ``SEC. 810. IMPORTATION BY INDIVIDUALS OF PRESCRIPTION DRUGS FROM CANADA. ``(a) In General.--Notwithstanding any other provision of this Act, not later than 180 days after the date of enactment of this section, the Secretary shall promulgate regulations permitting individuals to safely import into the United States a prescription drug (other than a controlled substance, as defined in section 102 of the Controlled Substances Act) that-- ``(1) is purchased from an approved Canadian pharmacy; ``(2) is dispensed by a pharmacist licensed to practice pharmacy and dispense prescription drugs in Canada; ``(3) is purchased for personal use by the individual, not for resale, in quantities that do not exceed a 90-day supply; ``(4) is filled using a valid prescription issued by a physician licensed to practice in the United States; and ``(5) has the same active ingredient or ingredients, route of administration, dosage form, and strength as a prescription drug approved by the Secretary under chapter V. ``(b) Approved Canadian Pharmacy.-- ``(1) In general.--In this section, an approved Canadian pharmacy is a pharmacy that-- ``(A) is located in Canada; and ``(B) that the Secretary certifies-- ``(i) is licensed to operate and dispense prescription drugs to individuals in Canada; and ``(ii) meets the criteria under subsection (c). ``(2) Publication of approved canadian pharmacies.--The Secretary shall publish on the Internet Web site of the Food and Drug Administration a list of approved Canadian pharmacies, including the Internet Web site address of each such approved Canadian pharmacy, from which individuals may purchase prescription drugs in accordance with subsection (a). ``(c) Additional Criteria.--To be an approved Canadian pharmacy, the Secretary shall certify that the pharmacy-- ``(1) has been in existence for a period of at least 5 years preceding the date of enactment of this section and has a purpose other than to participate in the program established under this section; ``(2) operates in accordance with pharmacy standards set forth by the provincial pharmacy rules and regulations enacted in Canada; ``(3) has processes established by the pharmacy, or participates in another established process, to certify that the physical premises [[Page S3289]] and data reporting procedures and licenses are in compliance with all applicable laws and regulations, and has implemented policies designed to monitor ongoing compliance with such laws and regulations; ``(4) conducts or commits to participate in ongoing and comprehensive quality assurance programs and implements such quality assurance measures, including blind testing, to ensure the veracity and reliability of the findings of the quality assurance program; ``(5) agrees that laboratories approved by the Secretary shall be used to conduct product testing to determine the safety and efficacy of sample pharmaceutical products; ``(6) has established, or will establish or participate in, a process for resolving grievances and will be held accountable for violations of established guidelines and rules; ``(7) does not resell products from online pharmacies located outside Canada to customers in the United States; and ``(8) meets any other criteria established by the Secretary.''. ______